244 related articles for article (PubMed ID: 32653835)
1. Prognostic alternative mRNA splicing signatures and associated splicing factors in acute myeloid leukemia.
Jin P; Tan Y; Zhang W; Li J; Wang K
Neoplasia; 2020 Sep; 22(9):447-457. PubMed ID: 32653835
[TBL] [Abstract][Full Text] [Related]
2. Identification of survival-related alternative splicing signatures in acute myeloid leukemia.
Zhang B; Yang L; Wang X; Fu D
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34212178
[TBL] [Abstract][Full Text] [Related]
3. Effects of Alternative Splicing Events on Acute Myeloid Leukemia.
Chen SL; Dai YJ; Hu F; Wang Y; Li H; Liang Y
DNA Cell Biol; 2020 Nov; 39(11):2040-2051. PubMed ID: 32915082
[TBL] [Abstract][Full Text] [Related]
4. High Wilms' tumor 1 associating protein expression predicts poor prognosis in acute myeloid leukemia and regulates m
Naren D; Yan T; Gong Y; Huang J; Zhang D; Sang L; Zheng X; Li Y
J Cancer Res Clin Oncol; 2021 Jan; 147(1):33-47. PubMed ID: 32880751
[TBL] [Abstract][Full Text] [Related]
5. A novel 4-mRNA signature predicts the overall survival in acute myeloid leukemia.
Chen Z; Song J; Wang W; Bai J; Zhang Y; Shi J; Bai J; Zhou Y
Am J Hematol; 2021 Nov; 96(11):1385-1395. PubMed ID: 34339537
[TBL] [Abstract][Full Text] [Related]
6. Identification of circRNA-lncRNA-miRNA-mRNA Competitive Endogenous RNA Network as Novel Prognostic Markers for Acute Myeloid Leukemia.
Cheng Y; Su Y; Wang S; Liu Y; Jin L; Wan Q; Liu Y; Li C; Sang X; Yang L; Liu C; Wang Z
Genes (Basel); 2020 Jul; 11(8):. PubMed ID: 32751923
[TBL] [Abstract][Full Text] [Related]
7. Genome-Wide Analysis of Prognostic Alternative Splicing Signature and Splicing Factors in Lung Adenocarcinoma.
Chang YS; Tu SJ; Chiang HS; Yen JC; Lee YT; Fang HY; Chang JG
Genes (Basel); 2020 Oct; 11(11):. PubMed ID: 33142748
[TBL] [Abstract][Full Text] [Related]
8. RNA Splicing Alterations Induce a Cellular Stress Response Associated with Poor Prognosis in Acute Myeloid Leukemia.
Anande G; Deshpande NP; Mareschal S; Batcha AMN; Hampton HR; Herold T; Lehmann S; Wilkins MR; Wong JWH; Unnikrishnan A; Pimanda JE
Clin Cancer Res; 2020 Jul; 26(14):3597-3607. PubMed ID: 32122925
[TBL] [Abstract][Full Text] [Related]
9. Incorporation of long non-coding RNA expression profile in the 2017 ELN risk classification can improve prognostic prediction of acute myeloid leukemia patients.
Tsai CH; Yao CY; Tien FM; Tang JL; Kuo YY; Chiu YC; Lin CC; Tseng MH; Peng YL; Liu MC; Liu CW; Yao M; Lin LI; Chou WC; Chen CY; Hou HA; Tien HF
EBioMedicine; 2019 Feb; 40():240-250. PubMed ID: 30662003
[TBL] [Abstract][Full Text] [Related]
10. Development and Validation of a Novel RNA Sequencing-Based Prognostic Score for Acute Myeloid Leukemia.
Wang M; Lindberg J; Klevebring D; Nilsson C; Lehmann S; Grönberg H; Rantalainen M
J Natl Cancer Inst; 2018 Oct; 110(10):1094-1101. PubMed ID: 29506270
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive Characterization of the Prognosis Value of Alternative Splicing Events in Acute Myeloid Leukemia.
Chen XX; Zhu JH; Li ZP; Xiao HT; Zhou H
DNA Cell Biol; 2020 Jul; 39(7):1243-1255. PubMed ID: 32543226
[TBL] [Abstract][Full Text] [Related]
12. Development of a nomogram for prognostic prediction of lower-grade glioma based on alternative splicing signatures.
Wang Y; Wang Z; Zhao B; Chen W; Wang Y; Ma W
Cancer Med; 2020 Dec; 9(24):9266-9281. PubMed ID: 33047900
[TBL] [Abstract][Full Text] [Related]
13. Validation of risk stratification models in acute myeloid leukemia using sequencing-based molecular profiling.
Wang M; Lindberg J; Klevebring D; Nilsson C; Mer AS; Rantalainen M; Lehmann S; Grönberg H
Leukemia; 2017 Oct; 31(10):2029-2036. PubMed ID: 28167833
[TBL] [Abstract][Full Text] [Related]
14. Characterization of alternative splicing events and prognostic signatures in breast cancer.
Han P; Zhu J; Feng G; Wang Z; Ding Y
BMC Cancer; 2021 May; 21(1):587. PubMed ID: 34022836
[TBL] [Abstract][Full Text] [Related]
15. The stem cell-associated gene expression signature allows risk stratification in pediatric acute myeloid leukemia.
Duployez N; Marceau-Renaut A; Villenet C; Petit A; Rousseau A; Ng SWK; Paquet A; Gonzales F; Barthélémy A; Leprêtre F; Pottier N; Nelken B; Michel G; Baruchel A; Bertrand Y; Leverger G; Lapillonne H; Figeac M; Dick JE; Wang JCY; Preudhomme C; Cheok M
Leukemia; 2019 Feb; 33(2):348-357. PubMed ID: 30089916
[TBL] [Abstract][Full Text] [Related]
16. Prognostic alternative splicing regulatory network of splicing events in acute myeloid leukemia patients based on SpliceSeq data from 136 cases.
Xie ZC; Gao L; Chen G; Ma J; Yang LH; He RQ; Li MW; Cai KT; Li TT; Peng ZG
Neoplasma; 2020 May; 67(3):623-635. PubMed ID: 32039631
[TBL] [Abstract][Full Text] [Related]
17. Systematic Profile Analysis of Prognostic Alternative Messenger RNA Splicing Signatures and Splicing Factors in Head and Neck Squamous Cell Carcinoma.
Xing L; Zhang X; Tong D
DNA Cell Biol; 2019 Jul; 38(7):627-638. PubMed ID: 31025877
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the clinical significance of global mRNA alternative splicing in patients with acute myeloid leukemia.
Yang YT; Yao CY; Chiu PJ; Kao CJ; Hou HA; Lin CC; Chou WC; Tien HF
Am J Hematol; 2023 May; 98(5):784-793. PubMed ID: 36855936
[TBL] [Abstract][Full Text] [Related]
19. LINC00649 underexpression is an adverse prognostic marker in acute myeloid leukemia.
Guo C; Gao YY; Ju QQ; Zhang CX; Gong M; Li ZL
BMC Cancer; 2020 Sep; 20(1):841. PubMed ID: 32883226
[TBL] [Abstract][Full Text] [Related]
20. High IL2RA mRNA expression is an independent adverse prognostic biomarker in core binding factor and intermediate-risk acute myeloid leukemia.
Du W; He J; Zhou W; Shu S; Li J; Liu W; Deng Y; Lu C; Lin S; Ma Y; He Y; Zheng J; Zhu J; Bai L; Li X; Yao J; Hu D; Gu S; Li H; Guo A; Huang S; Feng X; Hu D
J Transl Med; 2019 Jun; 17(1):191. PubMed ID: 31171000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
